Company Overview
Marex Group Limited, a financial services platform company, provides liquidity, market access, and infrastructure services to clients in the commodity and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and fixed income, financial securities, digital assets, and equity futures and options; liquidity, execution, and risk management solutions to financial markets. It also provides liquidity to clients in the OTC energy markets; market data, analytics, and market commentary; energy services, including gas, power, environmental, and crude oil markets; and market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across a spectrum of markets, including agriculture, currency, and interest rate markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the digital assets business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, hedge funds, crypto-native trading firms, crypto exchange-traded product (ETP) providers, proprietary trading firms, independent asset managers, family offices, pension funds, index providers, and corporates; and a portfolio of structured Notes, OTC derivatives, crypto-settled instruments, CME crypto futures, cash and carry, and bitcoin and ethereum ETF. Additionally, the company offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. Marex Group Limited was incorporated in 2005 and is based in London, the United Kingdom.
Why Investors Should Care
Generates a return on equity of 29.1%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 31.6%.
Net profit has compounded at 46.2% per year over the last five years.
Revenue has grown at a 45.6% CAGR over the past five years.
Trades at an undemanding P/E of 14.8.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $3.63B (+25.4% YoY); net profit $307.20M.
- Trailing 12 Months Year-on-year growth — revenue +55.1%, earnings +55.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 45.6%, profit CAGR 46.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 45.63% |
| 1 Year: | 55.10% |
Compounded Profit Growth
| 5 Years: | 46.25% |
| 1 Year: | 55.40% |
Stock Price Performance
| 1 Year: | +69.83% |
| 6 Months: | +68.82% |
| 3 Months: | +22.66% |
| 1 Month: | +5.02% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)54.34 · Neutral
P/E of 14.76 is above the sector median of 13.52 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 29.1%.
- Healthy ROCE of 31.6%.
- Compounding revenue at 45.6% over 5 years.
- Profit CAGR of 46.2% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MRX Marex Group Limited R2K | 65.07 | 14.76 | $4.68B | 0.97% | 31.55% | 29.06% | 45.63% | 46.25% |
| 2 | JPM JPMorgan Chase & Co. SPX | 346.91 | 16.61 | $929.55B | 1.87% | - | 16.47% | 5.35% | 7.56% |
| 3 | BRK-B Berkshire Hathaway Inc. SPX | 488.35 | 14.54 | $682.86B | 0.00% | - | 10.50% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPX | 355.14 | 30.99 | $589.43B | 0.75% | 37.15% | 60.35% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPX | 535.21 | 30.99 | $469.40B | 0.65% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPX | 61.59 | 15.28 | $432.24B | 1.88% | - | 10.64% | 6.00% | 3.49% |
| 7 | MS Morgan Stanley SPX | 228.55 | 20.70 | $360.49B | 1.76% | - | 16.39% | 3.76% | 9.66% |
| 8 | GS The Goldman Sachs Group, Inc. SPX | 1,152.07 | 17.79 | $339.87B | 1.58% | - | 16.95% | - | 2.21% |
| 9 | WFC Wells Fargo & Company SPX | 87.51 | 13.53 | $267.80B | 2.11% | - | 12.03% | 4.02% | 15.98% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 865.70M | 500.10M | 484.60M | 2.18B | 1.33B |
| Cost of Revenue | 544.70M | 305.90M | 292.00M | 1.03B | 845.50M |
| Gross Profit | 321.00M | 194.20M | 192.60M | 1.14B | 487.90M |
| Operating Expenses | 81.70M | 93.40M | 98.00M | 261.40M | 125.40M |
| Operating Income | 239.30M | 100.80M | 94.60M | 881.80M | 362.50M |
| EBITDA | 251.30M | 109.40M | 104.20M | 892.50M | 377.90M |
| Interest Expense | 145.40M | - | - | - | 216.40M |
| Pretax Income | 98.00M | 103.60M | 98.80M | 111.20M | 149.80M |
| Tax Provision | 25.50M | 26.90M | 25.60M | 25.70M | 37.50M |
| Net Income | 72.50M | 76.70M | 73.20M | 84.80M | 112.40M |
| Diluted EPS | 0.92 | 0.98 | 0.92 | 1.19 | 1.43 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 1.18B | 2.35B | 2.89B | 3.63B |
| Cost of Revenue | - | 681.70M | 1.32B | 1.61B | 1.92B |
| Gross Profit | - | 493.60M | 1.03B | 1.29B | 1.71B |
| Operating Expenses | - | 223.10M | 356.50M | 450.90M | 534.50M |
| Operating Income | - | 270.50M | 678.30M | 836.30M | 1.17B |
| EBITDA | - | 300.40M | 693.80M | 863.40M | 1.21B |
| Interest Expense | - | 165.00M | 470.20M | 538.10M | 760.20M |
| Pretax Income | - | 121.60M | 196.50M | 295.80M | 411.60M |
| Tax Provision | - | 23.40M | 55.20M | 77.80M | 103.70M |
| Net Income | - | 98.20M | 141.30M | 218.00M | 307.20M |
| Diluted EPS | - | 1.29 | 1.81 | 2.72 | 4.29 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 15.74B | 17.61B | 24.31B | 34.68B |
| Current Assets | - | 15.35B | 16.94B | 23.83B | 33.70B |
| Cash & Equivalents | - | 910.10M | 1.48B | 2.56B | 2.88B |
| Inventory | - | 35.80M | 163.40M | 35.80M | 483.70M |
| Receivables | - | 4.69B | 2.03B | 3.72B | 10.99B |
| Total Liabilities | - | 15.07B | 16.84B | 23.34B | 33.41B |
| Current Liabilities | - | 14.56B | 15.88B | 21.78B | 30.96B |
| Long Term Debt | - | 472.10M | 907.90M | 1.48B | 2.33B |
| Total Debt | - | 5.73B | 5.39B | 6.14B | 10.23B |
| Total Equity | - | 677.70M | 775.90M | 976.90M | 1.26B |
| Shares Outstanding | - | 70.82M | 70.29M | 72.22M | 72.94M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 225.60M | 735.00M | 1.16B | 667.50M |
| Investing Cash Flow | - | -46.30M | -97.60M | -35.30M | -264.30M |
| Financing Cash Flow | - | 26.50M | -72.80M | -37.20M | -123.90M |
| Capital Expenditure | - | -9.40M | -12.10M | -19.90M | -19.80M |
| Free Cash Flow | - | 216.20M | 722.90M | 1.14B | 647.70M |
| Net Change in Cash | - | 205.80M | 564.60M | 1.09B | 279.30M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 42.0% | 44.0% | 44.5% | 47.0% |
| Operating Margin % | - | 23.0% | 28.8% | 28.9% | 32.3% |
| Net Margin % | - | 8.4% | 6.0% | 7.5% | 8.5% |
| ROE % | - | 14.5% | 18.2% | 22.3% | 24.3% |
| ROCE % | - | 22.9% | 39.3% | 33.0% | 31.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 6.02% | 4.39M | $285.53M |
| 2 | Capital International Investors | 4.78% | 3.49M | $226.90M |
| 3 | FMR, LLC | 4.77% | 3.48M | $226.50M |
| 4 | LOOMIS SAYLES & CO L P | 2.63% | 1.92M | $124.81M |
| 5 | Price (T.Rowe) Associates Inc | 2.61% | 1.91M | $123.99M |
| 6 | Alliancebernstein L.P. | 2.37% | 1.73M | $112.54M |
| 7 | Samlyn Capital, LLC | 2.32% | 1.69M | $109.86M |
| 8 | Two Sigma Investments, LP | 2.31% | 1.68M | $109.39M |
| 9 | Jennison Associates LLC | 2.20% | 1.61M | $104.52M |
| 10 | William Blair Investment Management, LLC | 2.15% | 1.57M | $101.88M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MRX
Marex Group Ltd (MRX) officer’s 16,666-share 10b5-1 stock sale detailed - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQT3ozNHZpbnJ1bXVvdEJNVjlwdHo4dzBGVkh6RFJfOXhwYWh3by1HZ3JJNXZhRlVza3ktMGs2RTB5MXhOZGlnbHpWcnNjSzVTbk5TbU1KR3BneWcwc0loUUZwYnlfdXd5XzQxQXdhWkRIVnpKZUhxaTNLcmxvM1FaV2dnLWtpTzk2eGJYYl…
Keefe Bruyette Lifts PT on Marex Group (MRX), Names it Top Pick - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQVzh2U1JwVUQ5SGwwWERhaUZFeEV2aTVYUEpaSGhKbWZ3cWZBUTdMbnU3aktnc0R5YURrQy1VY2JDZHZWTjNxNkdyTVhoZlY5S1IwU1l2Y3BPSWJjTWtPc2IzTlZsLXQyY3ZSRHNuZk9Bb2c2eHVJeTRESVBoUFhRQlpDa3MxM3FWemlCeH…
Marex Group (MRX) CEO sells 37,142 shares, retains 2,803,960 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNQXR5eWZRcjJ3TFVhZWowb21fRVVTdlUyYWM1WXlwWDBsZFRmOGd2NGNiZWoyWVNDX2FhTk5pUnFwbVRoQUxlY253N0ZVRV8wYU1VVnUyaFM3cEQ1TW5lMjVyT1dnS3lGa1VqVnh2SHJZZVJVNS15Ny1mdkpsOW94OGxsUnVIbUNVcThoSE…
Understanding the Setup: (MRX) and Scalable Risk - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOYkhLV0VCRGdGNTZsN1V5NlhYZkJBM2ZKeXZJVE5RREdqeUFOWm9xNXh3M2lKa0pYVVRodnpFZU1UTzJJWnlPWXJyY19fVEtTanlxQlg2aG1hSXhlNE4zTmtvRkNMczJnWnVtTms5dzFGVWhLcFM5Y0JGUFZtRVRIR25Eclg2UmxVT0xfRE…
Keefe, Bruyette & Woods Forecasts Strong Price Appreciation for Marex Group plc Ordinary Shares (NASDAQ:MRX) Stock - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxPQUUtOUhHamxUMmg4OGdFNWo5WmlacFhIYy05azc3NmpJZUlXN1Y1Q2NYTGpld2xidjVZeFNWS0l5SWFoeUFlWGRzR0h0NkNLV01DU1FTT0lqY3h0Rk1rVnVjaE5lX0dVZTdiM3ExUDh3NGdCcVlBRXd1VTRVRkZJNnlhMWIyV3lEVVNpRF…
Is Marex Group (MRX) Fully Valued Following Its Russell Defensive Index Exit? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxPdm9QaDFMTUgzY2lkZDVQUVgwcUNtbXdLZ2lpWnNjMXNtTUtrYjNWQmhidzc3ZndZM2praF9McUZiazVkRGpLNTM3R0VzOXlHUTRYdnF3T0pjeGNfdmc4RmVMN1kyM0laWVI3d2dIUE5oLUVMdVg4d3lSRk5MVlJBaEJuWjk1eUVPRzZVUm…
MRX — Frequently Asked Questions
What is the current share price of Marex Group Limited (MRX)?
As of 2026-07-15 16:51 PDT, Marex Group Limited (MRX) trades at $65.07 on NasdaqGS. Its 52-week range is $27.92 to $70.29.
What is the market capitalisation of MRX?
Marex Group Limited (MRX) has a market capitalisation of $4.68B on NasdaqGS.
What is the P/E ratio of MRX?
MRX trades at a trailing price-to-earnings (P/E) ratio of 14.76. The industry average P/E is 13.52. Its price-to-book (P/B) ratio is 3.73.
Does MRX pay a dividend?
Marex Group Limited (MRX) currently offers a dividend yield of 0.97%.
What is the return on equity (ROE) of MRX?
MRX has a return on equity (ROE) of 29.06%. Its return on capital employed (ROCE) is 31.55%.
Is MRX a good stock to buy?
This page provides a data-driven analysis of Marex Group Limited (MRX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.